Trump行政主管为15种药物取得了较低的医疗保险价格,从2027年开始,节省了8.5B美元。 The Trump admin secured lower Medicare prices for 15 drugs, with savings up to $8.5B, starting in 2027.

特朗普政府宣布,制药公司已同意降低15种高价药品(包括Ozempic、Wegovy和Rybelsus)的医疗保险价格,新的价格于2027年生效。 The Trump administration announced that pharmaceutical companies have agreed to lower Medicare prices for 15 high-cost drugs, including Ozempic, Wegovy, and Rybelsus, with the new rates taking effect in 2027. 这标志着根据2022年的一项法律进行的第二轮谈判,该法允许医疗保险公司谈判药品价格,使总数达到25种药物。 This marks the second round of negotiations under a 2022 law allowing Medicare to negotiate drug prices, bringing the total to 25 drugs. 行政当局声称,这些交易如果适用于2024年,可节省85亿美元的净支出,超过拜登方案下的第一轮。 The administration claims the deals could save $8.5 billion in net spending if applied to 2024, surpassing the first round under Biden. 虽然受益人的最后自付费用将因计划而异,但新规则规定每年支出上限为2 000美元。 While final out-of-pocket costs for beneficiaries will vary by plan, a new rule caps annual spending at $2,000. 卫生部长罗伯特·肯尼迪(Robert F. Kennedy Jr.)说,这一进展反映了政府承诺降低老年人的医疗保健费用。 Health Secretary Robert F. Kennedy Jr. said the progress reflects the administration’s commitment to lowering healthcare costs for seniors.